Akero Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
601 Gateway Boulevard, Suite 350, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/8/2024, 07:32 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Sep 15, 2022
SC 13D/A Report SC 13D/A Jun 29, 2021
SC 13D/A Report SC 13D/A May 7, 2021
SC 13D/A Report Sep 9, 2020
SC 13D/A Report AMENDMENT NO. 1 TO SCHEDULE 13D Jul 14, 2020
SC 13D/A Report Jul 8, 2020
SC 13D/A Report SC 13D/A Jan 15, 2020
SC 13D Report SC 13D Jul 1, 2019
SC 13D Report SC 13D Jun 26, 2019